Alzinova
Alzinova: Completes Preclinical Humanization of ALZ-201 (Redeye)
2022-01-21 10:00
Redeye is encouraged by the news that Alzinova has successfully completed the humanization work, and selected a humanized lead candidate, of its monoclonal antibody ALZ-201.
info@redeye.se (Redeye.se)
Redeye AB - Redeye.se